These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30014505)

  • 1. Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion.
    Benatar M; Wuu J; Andersen PM; Lombardi V; Malaspina A
    Ann Neurol; 2018 Jul; 84(1):130-139. PubMed ID: 30014505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilaments in pre-symptomatic ALS and the impact of genotype.
    Benatar M; Wuu J; Lombardi V; Jeromin A; Bowser R; Andersen PM; Malaspina A
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):538-548. PubMed ID: 31432691
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
    Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A
    Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity.
    Benatar M; Granit V; Andersen PM; Grignon AL; McHutchison C; Cosentino S; Malaspina A; Wuu J
    Brain; 2022 Oct; 145(10):3500-3508. PubMed ID: 35594156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
    Benatar M; Wuu J; Andersen PM; Bucelli RC; Andrews JA; Otto M; Farahany NA; Harrington EA; Chen W; Mitchell AA; Ferguson T; Chew S; Gedney L; Oakley S; Heo J; Chary S; Fanning L; Graham D; Sun P; Liu Y; Wong J; Fradette S
    Neurotherapeutics; 2022 Jul; 19(4):1248-1258. PubMed ID: 35585374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers.
    Dorst J; Weydt P; Brenner D; Witzel S; Kandler K; Huss A; Herrmann C; Wiesenfarth M; Knehr A; Günther K; Müller K; Weishaupt JH; Prudlo J; Forsberg K; Andersen PM; Rosenbohm A; Schuster J; Roselli F; Dupuis L; Mayer B; Tumani H; Kassubek J; Ludolph AC
    EBioMedicine; 2023 Apr; 90():104521. PubMed ID: 36917918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Shahim P; Norato G; Sinaii N; Zetterberg H; Blennow K; Chan L; Grunseich C
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.
    Gray E; Thompson AG; Wuu J; Pelt J; Talbot K; Benatar M; Turner MR
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1296-1306. PubMed ID: 32666680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma NfL levels and longitudinal change rates in
    Saracino D; Dorgham K; Camuzat A; Rinaldi D; Rametti-Lacroux A; Houot M; Clot F; Martin-Hardy P; Jornea L; Azuar C; Migliaccio R; Pasquier F; Couratier P; Auriacombe S; Sauvée M; Boutoleau-Bretonnière C; Pariente J; Didic M; Hannequin D; Wallon D; ; ; Colliot O; Dubois B; Brice A; Levy R; Forlani S; Le Ber I
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1278-1288. PubMed ID: 34349004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.
    Steinacker P; Huss A; Mayer B; Grehl T; Grosskreutz J; Borck G; Kuhle J; Lulé D; Meyer T; Oeckl P; Petri S; Weishaupt J; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):112-119. PubMed ID: 27819158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
    Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M
    Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.
    Feneberg E; Oeckl P; Steinacker P; Verde F; Barro C; Van Damme P; Gray E; Grosskreutz J; Jardel C; Kuhle J; Koerner S; Lamari F; Amador MDM; Mayer B; Morelli C; Muckova P; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Stubendorff B; Turner MR; Verbeek MM; Weishaupt JH; Weydt P; Ludolph AC; Otto M
    Neurology; 2018 Jan; 90(1):e22-e30. PubMed ID: 29212830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal biomarkers in amyotrophic lateral sclerosis.
    Huang F; Zhu Y; Hsiao-Nakamoto J; Tang X; Dugas JC; Moscovitch-Lopatin M; Glass JD; Brown RH; Ladha SS; Lacomis D; Harris JM; Scearce-Levie K; Ho C; Bowser R; Berry JD
    Ann Clin Transl Neurol; 2020 Jul; 7(7):1103-1116. PubMed ID: 32515902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of CSF NfL and tau in ALS.
    Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
    J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS.
    Kasai T; Kojima Y; Ohmichi T; Tatebe H; Tsuji Y; Noto YI; Kitani-Morii F; Shinomoto M; Allsop D; Mizuno T; Tokuda T
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2489-2502. PubMed ID: 31742901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.
    Poesen K; De Schaepdryver M; Stubendorff B; Gille B; Muckova P; Wendler S; Prell T; Ringer TM; Rhode H; Stevens O; Claeys KG; Couwelier G; D'Hondt A; Lamaire N; Tilkin P; Van Reijen D; Gourmaud S; Fedtke N; Heiling B; Rumpel M; Rödiger A; Gunkel A; Witte OW; Paquet C; Vandenberghe R; Grosskreutz J; Van Damme P
    Neurology; 2017 Jun; 88(24):2302-2309. PubMed ID: 28500227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
    Gaiottino J; Norgren N; Dobson R; Topping J; Nissim A; Malaspina A; Bestwick JP; Monsch AU; Regeniter A; Lindberg RL; Kappos L; Leppert D; Petzold A; Giovannoni G; Kuhle J
    PLoS One; 2013; 8(9):e75091. PubMed ID: 24073237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis.
    Gendron TF; ; Daughrity LM; Heckman MG; Diehl NN; Wuu J; Miller TM; Pastor P; Trojanowski JQ; Grossman M; Berry JD; Hu WT; Ratti A; Benatar M; Silani V; Glass JD; Floeter MK; Jeromin A; Boylan KB; Petrucelli L
    Ann Neurol; 2017 Jul; 82(1):139-146. PubMed ID: 28628244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.
    Gaiani A; Martinelli I; Bello L; Querin G; Puthenparampil M; Ruggero S; Toffanin E; Cagnin A; Briani C; Pegoraro E; Sorarù G
    JAMA Neurol; 2017 May; 74(5):525-532. PubMed ID: 28264096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.